Simultaneous Whole-Body PET/MR Imaging in Comparison to PET/CT in Pediatric Oncology: Initial Results
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
PURPOSE: To compare positron emission tomography (PET)/magnetic resonance (MR) imaging and PET/computed tomography (CT) for lesion detection and interpretation, quantification of fluorine 18 ((18)F) fluorodeoxyglucose (FDG) uptake, and accuracy of MR-based PET attenuation correction in pediatric patients with solid tumors. Materials and Methods This prospective study had local ethics committee and German Federal Institute for Drugs and Medical Devices approval. Written informed consent was obtained from all patients and legal guardians. Twenty whole-body (18)F-FDG PET/CT and (18)F-FDG PET/MR examinations were performed in 18 pediatric patients (median age, 14 years; range, 11-17 years). (18)F-FDG PET/CT and (18)F-FDG PET/MR data were acquired sequentially on the same day for all patients. PET standardized uptake values (SUVs) were quantified with volume of interest measurements in lesions and healthy tissues. MR-based PET attenuation correction was compared with CT-derived attenuation maps (µ-maps). Lesion detection was assessed with separate reading of PET/CT and PET/MR data. Estimates of radiation dose were derived from the applied doses of (18)F-FDG and CT protocol parameters. Descriptive statistical analyses were performed to report correlation coefficients and relative deviations for comparison of SUVs, rates of lesion detection, and percentage reductions in radiation dose. RESULTS: PET SUVs showed strong correlations between PET of PET/CT (PETCT) and PET of PET/MR (PETMR) (r > 0.85 for most tissues). Apart from drawbacks of MR-based PET attenuation correction in osseous structures and lungs, similar SUVs were found on PET images corrected with CT-based µ-maps (13.1% deviation of SUVs for bone marrow and <5% deviation for other tissues). Lesion detection rate with PET/MR imaging was equivalent to that with PET/CT (61 areas of focal uptake on PETMR images vs 62 areas on PETCT images). Advantages of PET/MR were observed especially in soft-tissue regions. Furthermore, PET/MR offered significant dose reduction (73%) compared with PET/CT. CONCLUSION: Pediatric oncologic PET/MR is technically feasible, showing satisfactory performance for PET quantification with SUVs similar to those of PET/CT. Compared with PET/CT, PET/MR demonstrates equivalent lesion detection rates while offering markedly reduced radiation exposure. Thus, PET/MR is a promising modality for the clinical work-up of pediatric malignancies. Online supplemental material is available for this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systematic underestimation of SUV in bone tissue or lesions close to the bone of >10% compared to PET/CT has been described [60,62], whereas SUV differences were <5% in other normal tissues [60].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [60]
In the citing paper
“However, several sources of error exist, including extracorporeal components such as headphones, dense hair or MR coils [59], incorrect attenuation correction factors for bone and lung tissue [60], incorrect segmentation of such compartments, and MR image truncation [61].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [60]
In the citing paper
“However, systematically different normal organ SUVs have been reported for [18F]FDG as well, which most likely result from MR-AC inaccuracies [60,65,66].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [60]
Citations
Cites
Elastix: a toolbox for intensity-based medical image registration
Klein, S., Staring, M., Murphy, K., Viergever, M. A., & Pluim, J. (2010) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2009.2035616 · Cited by 4,311
Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
Delso, G., Fürst, S., Jakoby, B., Ladebeck, R., Ganter, C., Nekolla, S. G., Schwaiger, M., & Ziegler, S. I. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092726 · Cited by 874
American Association of Physicists in Medicine
(1973) · Radiology · doi:10.1148/106.3.717b · Cited by 732
Drzezga, A., Souvatzoglou, M., Eiber, M., Beer, A. J., Fürst, S., Martinez-Möller, A., Nekolla, S. G., Ziegler, S., Ganter, C., Rummeny, E. J., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098608 · Cited by 508
Daldrup-Link, H. E., Franzius, C., Link, T. M., Laukamp, D., Sciuk, J., Jürgens, H., Schober, O., & Rummeny, E. J. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.1.1770229 · Cited by 444
Berker, Y., Franke, J., Salomon, A., Palmowski, M., Donker, H. C. W., Temur, Y., Mottaghy, F. M., Kuhl, C., Izquierdo-Garcia, D., Fayad, Z. A., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092577 · Cited by 344
Chawla, S. C., Federman, N., Zhang, D., Nagata, K., Nuthakki, S., McNitt-Gray, M., & Boechat, M. I. (2010) · Pediatric Radiology · doi:10.1007/s00247-009-1434-z · Cited by 218
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology
Stauss, J., Franzius, C., Pfluger, T., Juergens, K. U., Biassoni, L., Begent, J., Kluge, R., Amthauer, H., Voelker, T., Højgaard, L., et al. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0826-x · Cited by 190
Review of functional/anatomical imaging in oncology
Histed, S. N., Lindenberg, M. L., Mena, E., Turkbey, B., Choyke, P. L., & Kurdziel, K. A. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32834ec8a5 · Cited by 175
Pulmonary Lesion Assessment: Comparison of Whole-Body Hybrid MR/PET and PET/CT Imaging—Pilot Study
Schwenzer, N. F., Schraml, C., Müller, M., Brendle, C., Sauter, A. W., Spengler, W., Pfannenberg, A. C., Claussen, C. D., & Schmidt, H. (2012) · Radiology · doi:10.1148/radiol.12111942 · Cited by 160
Self-citation
Research works printed but not linked: 3
- Franzius C, 2010, Q J Nucl Med Mol Imaging, 54, 401
- Knopp MV, 2003, Mol Cancer Ther, 2, 419
- Bongartz G, 2004, Luxenbourg: European Commission
Cited by
Spick, C., Herrmann, K., & Czernin, J. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.158808 · Cited by 185
“However, comparative data have been reported for only 18 pediatric patients (Table 7) (83).”
BackgroundIs There Use for FDG-PET in Prostate Cancer?
Jadvar, H. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.07.004 · Cited by 160
Melsaether, A. N., Raad, R. A., Pujara, A. C., Ponzo, F., Pysarenko, K. M., Jhaveri, K. L., Babb, J. S., Sigmund, E. E., Kim, S., & Moy, L. P. (2016) · Radiology · doi:10.1148/radiol.2016151155 · Cited by 126
Martin, O., Schaarschmidt, B. M., Kirchner, J., Suntharalingam, S., Grueneisen, J. S., Demircioğlu, A., Heusch, P., Quick, H. H., Forsting, M., Antoch, G., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.233940 · Cited by 133
Hurley, C., McCarville, M. B., Shulkin, B. L., Mao, S., Wu, J., Navid, F., Daw, N. C., Pappo, A. S., & Bishop, M. W. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26014 · Cited by 105
“[4,18] Other novel whole-body imaging modalities including 18F-sodiumfluoride (18F-NaF) PET imaging,[20] wholebody MRI,[21] and hybrid PET–MRI [22] are being evaluated for detection of distantmetastases in adult and pediatric cancers and may be worthy of inclusion in future prospective studies for comparison with 18F-…”
Grueneisen, J. S., Schaarschmidt, B. M., Heubner, M. L., Suntharalingam, S., Milk, I., Kinner, S., Heubner, A., Forsting, M., Lauenstein, T. C., Ruhlmann, V., et al. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.08.010 · Cited by 89
“In a recent publication by Schaefer and colleagues, the authors reported a potential reduction in radiation exposure of 73% by using PET/MRI for a diagnostic work-up of pediatric cancer patients in comparison to PET/CT [7].”
BackgroundSher, A. C., Seghers, V. J., Paldino, M. J., Dodge, C. T., Krishnamurthy, R., Krishnamurthy, R., & ROHREN, E. M. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15083 · Cited by 84
“These findings are in-line with those of prior studies that illustrated that a dedicated anatomic MRI sequence, such as a Dixon sequence [9] or STIR and T2-weighted imaging sequences combined [13], are more appropriate for anatomic localization.”
BackgroundResultInfluentialQuantitative comparison of PET performance—Siemens Biograph mCT and mMR
Karlberg, A. M., Sæther, O., Eikenes, L., & Goa, P. E. (2016) · EJNMMI Physics · doi:10.1186/s40658-016-0142-7 · Cited by 79
The Role of MR Enterography in Assessing Crohn’s Disease Activity and Treatment Response
Moy, M. P., Sauk, J. S., & Gee, M. S. (2015) · Gastroenterology Research and Practice · doi:10.1155/2016/8168695 · Cited by 75
Optimization of Pediatric PET/CT
Parisi, M. T., Bermo, M. S., Alessio, A. M., Sharp, S. E., Gelfand, M. J., & Shulkin, B. L. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.01.002 · Cited by 71
Gatidis, S., Schmidt, H., Gücke, B., Bezrukov, I., Seitz, G., Ebinger, M., Reimold, M., Pfannenberg, C., Nikolaou, K., Schwenzer, N. F., et al. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000200 · Cited by 69
“These findings are in agreement with previous studies comparing diagnostic performance of PET/ CTand PET/MRI.9 In these studies, advantages of PET/MRI were seen in the detection of soft tissue lesions.”
BackgroundResultSelf-citationRuhlmann, V., Ruhlmann, M., Bellendorf, A., Grueneisen, J. S., Sawicki, L. M., Grafe, H., Forsting, M., Bockisch, A., & Umutlu, L. (2016) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.08.020 · Cited by 68
Sarabhai, T., Schaarschmidt, B. M., Wetter, A., Kirchner, J., Aktas, B., Forsting, M., Ruhlmann, V., Herrmann, K., Umutlu, L., & Grueneisen, J. S. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3809-y · Cited by 68
Bailey, D. L., Antoch, G., Bartenstein, P., Barthel, H., Beer, A. J., Bisdas, S., Bluemke, D. A., Boellaard, R., Claussen, C. D., Franzius, C., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0818-0 · Cited by 74
“It was shown that substantial reductions in effective patient radiation dose from ~25 mSv [67] for combined diagnostic CT and PET/CT exams to ~7 mSv for the PET/MRI examination can be achieved using the recommended activities for 3D acquisition of the European Association of Nuclear Medicine (EANM) guideline for [(18)…”
MethodSelf-citationComparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma
Afaq, A., Fraioli, F., Sidhu, H. S., Wan, S., Punwani, S., Chen, S.-H., Akın, O., Linch, D. C., Ardeshna, K. M., Lambert, J., et al. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001344 · Cited by 70
“Recently described in a pediatric population, PET/MRI can offer significant ionizing dose reduction: 73% (±11%) reduction in total effective dose in 1 study.(24) The length of scanning time is comparable for PET/MRI and PET/CT when anatomical sequences alone are performed.”
BackgroundEvaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma
Ponisio, M. R., McConathy, J., Laforest, R. A., & Khanna, G. (2016) · Pediatric Radiology · doi:10.1007/s00247-016-3601-3 · Cited by 61
“This is in contradistinction to the 73-80% radiation dose reduction reported in previous studies [20, 21].”
BackgroundResultCombined PET/MRI: Multi-modality Multi-parametric Imaging Is Here
Bailey, D. L., Pichler, B. J., Gückel, B., Barthel, H., Beer, A. J., Bremerich, J., Czernin, J. G., Drzezga, A. E., Franzius, C., Goh, V., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0886-9 · Cited by 74
“The use of PET/MRI in paediatric oncology imaging as a means for mitigating the radiation dose from the CT component of PET/CT examinations has been well recognised previously [29, 30].”
MethodSelf-citationSimultaneous PET/MRI vs. PET/CT in oncology. A systematic review
Riola-Parada, C., García‐Cañamaque, L., Pérez-Dueñas, V., Garcerant-Tafur, M., & Carreras-Delgado, J. L. (2016) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2016.06.006 · Cited by 62
Bailey, D. L., Pichler, B. J., Gückel, B., Antoch, G., Barthel, H., Bhujwalla, Z. M., Biskup, S., Biswal, S., Bitzer, M., Boellaard, R., et al. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1123-5 · Cited by 58
“From this, the areas where evidence exists that PET/MRI has been demonstrated to provide better information and characterisation of disease are in prostate cancer [23] and, as suggested previously at these workshops, in paediatric oncology [42].”
BackgroundSelf-citationInfluences on PET Quantification and Interpretation
Rogasch, J. M. M., Hofheinz, F., van Heek, L., Voltin, C.-A., Boellaard, R., & Kobe, C. (2022) · Diagnostics · doi:10.3390/diagnostics12020451 · Cited by 57
“However, several sources of error exist, including extracorporeal components such as headphones, dense hair or MR coils [59], incorrect attenuation correction factors for bone and lung tissue [60], incorrect segmentation of such compartments, and MR image truncation [61].”
BackgroundNeuroblastoma: MIBG Imaging and New Tracers
Pfluger, T., & Piccardo, A. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.10.007 · Cited by 57
MR Imaging–Guided Attenuation Correction of PET Data in PET/MR Imaging
Izquierdo-Garcia, D., & Catana, C. (2016) · PET Clinics · doi:10.1016/j.cpet.2015.10.002 · Cited by 53
Whole-body magnetic resonance imaging in children: technique and clinical applications
Eutsler, E. P., & Khanna, G. (2016) · Pediatric Radiology · doi:10.1007/s00247-016-3586-y · Cited by 51
“Good correlation has been shown between standardized uptake values estimated by PET/CT and PET/MR for both normal structures and pathological lesions in adults and children [31, 32].”
BackgroundArtificial intelligence applications for pediatric oncology imaging
Daldrup-Link, H. E. (2019) · Pediatric Radiology · doi:10.1007/s00247-019-04360-1 · Cited by 57
Bezrukov, I., Schmidt, H., Gatidis, S., Mantlik, F., Schäfer, J. F., Schwenzer, N. F., & Pichler, B. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.149476 · Cited by 50
“Pediatric imaging is regarded as one of the key applications for combined PET/MR imaging systems (1,2), as the reduction of”
MethodSelf-citationWhole-Body PET/MRI Applications in Pediatric Oncology
States, L. J., & Reid, J. R. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.19.22677 · Cited by 53
Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI
Gatidis, S., Schmidt, H., la Fougère, C., Nikolaou, K., Schwenzer, N. F., & Schäfer, J. F. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3503-5 · Cited by 48
“A significant reduction in radiation exposure by up to 70% can be achieved by replacing CT with MRI using combined (18)F-FDG-PET/MRI [8, 9].”
BackgroundMethodSelf-citationPET/RM simultánea vs. PET/TC en oncología. Una revisión sistemática
Riola-Parada, C., García‐Cañamaque, L., Pérez-Dueñas, V., Garcerant-Tafur, M., & Carreras-Delgado, J. L. (2016) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2016.06.001 · Cited by 54
Gatidis, S., Bender, B., Reimold, M., & Schäfer, J. F. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.01.018 · Cited by 48
Self-citationTechnical and instrumentational foundations of PET/MRI
Rausch, I., Quick, H. H., Cal-González, J., Sattler, B., Boellaard, R., & Beyer, T. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.04.004 · Cited by 47
Reinert, C. P., Schuhmann, M. U., Bender, B., Gugel, I., la Fougère, C., Schäfer, J. F., & Gatidis, S. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4227-5 · Cited by 49
Self-citationEvaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI
Grueneisen, J. S., Sawicki, L. M., Schaarschmidt, B. M., Suntharalingam, S., von der Ropp, S., Wetter, A., Ruhlmann, V., Quick, H. H., Forsting, M., & Umutlu, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157880 · Cited by 47
18F-FDG PET/CT in the Management of Osteosarcoma
Oh, C., Bishop, M. W., Cho, S. Y., Im, H., & Shulkin, B. L. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265592 · Cited by 50
“Sch€afer reported that PET/MRI showed a 73% reduction in radiation exposure compared with PET/CT and demonstrated an identical rate of detecting lesions (59).”
BackgroundPujara, A. C., Kim, E. S., Axelrod, D., & Melsaether, A. N. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26298 · Cited by 45
Whole-Body MRI in Children: Current Imaging Techniques and Clinical Applications
Goo, H. W. (2015) · Korean Journal of Radiology · doi:10.3348/kjr.2015.16.5.973 · Cited by 41
“MR/PET offers equivalent lesion detection rates and advantages during a soft tissue evaluation compared with those of PET/CT (27).”
MethodInfluentialFDG Whole-Body PET/MRI in Oncology: a Systematic Review
Kwon, H. W., Becker, A.-K., Goo, J. M., & Cheon, G. J. (2016) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-016-0411-3 · Cited by 43
“mance of PET/MR showed comparable to that of PET/CT (61 focal uptakes among 62 focal uptakes on PET/CT) [73].”
BackgroundPET/MRI Improves Management of Children with Cancer
Baratto, L., Hawk, K. E., States, L. J., Qi, J., Gatidis, S., Kiru, L., & Daldrup-Link, H. E. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.259747 · Cited by 46
“SUVs on PET/MRI based on segmented attenuation maps are lower than those on PET/CT using transmission-based attenuation correction (6,20,22,23).”
BackgroundMethodSelf-citationPaldino, M. J., Yang, E., Jones, J. Y., Mahmood, N., Sher, A. C., Zhang, W., Hayatghaibi, S. E., Krishnamurthy, R., & Seghers, V. J. (2017) · Pediatric Radiology · doi:10.1007/s00247-017-3888-8 · Cited by 40
“However, our results are also in line with prior work using FDG-PET/MR in several oncological populations, including adult head and neck tumors [29], bone tumors [30], lung cancer [31] and a general pediatric oncological cohort [32], which has demonstrated no statistical difference in diagnostic performance compared w…”
ResultGatidis, S., Würslin, C., Seith, F., Jf, S., la Fougère, C., Nikolaou, K., Schwenzer, N., & Schmidt, H. (2016) · PubMed · doi:10.1967/s002449910333 · Cited by 45
“Hell J Nucl Med 2016; 19(1): 15-18 Epub ahead of print: 1 March 2016 Published online: 1 April 2016”
BackgroundSelf-citationLyons, K. A., Seghers, V. J., Sorensen, J. I. L., Zhang, W., Paldino, M. J., Krishnamurthy, R., & ROHREN, E. M. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.15.14304 · Cited by 38
“[8] of 18 children who underwent 20 PET/MRI examinations, both false-positive and false-negative focal areas of uptake were reported in the thorax.”
BackgroundInfluentialWhole-body MRI in paediatric oncology
Nievelstein, R. A. J., & Littooij, A. S. (2015) · La radiologia medica · doi:10.1007/s11547-015-0600-7 · Cited by 39
Evaluation of Prostate Cancer with PET/MRI
Lindenberg, L., Ahlman, M. A., Türkbey, B., Mena, E., & Choyke, P. L. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.169763 · Cited by 40
“The CT component of a PET/CT scan contributes approximately 73% of the total effective dose unless modern low-dose CT techniques are used (32).”
MethodWorkflow in Simultaneous PET/MRI
Barbosa, F. D. G., von Schulthess, G. K., & Veit‐Haibach, P. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2015.03.007 · Cited by 35
Muehe, A. M., Theruvath, A. J., Lai, L. M., Aghighi, M., Quon, A. S. W., Holdsworth, S. J., Wang, J., Luna‐Fineman, S., Marina, N. M., Advani, R. H., et al. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1105-7 · Cited by 37
“[18], who reported that PET/MR changed initial staging compared to PET/CT in 25 % of patients and Hirsch et al.”
Backgroundde Jesus, F. M., Kwee, T. C., Nijland, M., Kahle, X. U., Huls, G. A., Dierckx, R., van Meerten, T., Gheysens, O. S., Dierickx, D., Vergote, V. K. J., et al. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.09.007 · Cited by 37
The Promise of Hybrid PET\/MRI: Technical advances and clinical applications
Zaidi, H., & Becker, M. (2016) · IEEE Signal Processing Magazine · doi:10.1109/msp.2015.2482225 · Cited by 33
“From a clinical perspective, some incremental progress has been reported over the past two years in breast cancer [81], pediatric oncology [96], prostate cancer [82], head and neck chondrosarcoma [83], and neck irradiation [106], whereas no added value compared with other imaging modalities (PET/CT or MRI) could be de…”
BackgroundResultInfluentialDiagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease.
Catalano, O. A., Wu, V., Mahmood, U., Signore, A., Vangel, M. G., Soricelli, A., Salvatore, M., Gervais, D. A., & Rosen, B. R. (2018) · Europe PMC (PubMed Central) · Cited by 36
Schmall, J. P., Surti, S., Otero, H. J., Servaes, S. E., Karp, J. S., & States, L. J. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.240127 · Cited by 35
“In these cases the PET SUV will be an important metric, and quantitation is therefore critical (33,34).”
BackgroundSeith, F., Schmidt, H., Kunz, J., Küstner, T., Gatidis, S., Nikolaou, K., la Fougère, C. J., & Schwenzer, N. F. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.184440 · Cited by 33
“of PET detectors in current PET/MRI scanners (16,17) and commonly longer PET acquisition times than PET/CT acquisition times (18,19), a reduction of PET tracer doses might be feasible for PET/MRI examinations.”
BackgroundSelf-citationKwatra, N. S., Lim, R., Gee, M. S., States, L. J., Vossough, A., & Lee, E. Y. (2019) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2019.01.012 · Cited by 35
How PET/MR Can Add Value for Children with Cancer
Daldrup-Link, H. E. (2017) · Current Radiology Reports · doi:10.1007/s40134-017-0207-y · Cited by 33
“Single center investigations of (18)F-FDG PET/ MR scans for pediatric cancer staging obtained so far cover a limited number of patients with a wide variety of pediatric tumors [11, 12].”
Grueneisen, J. S., Sawicki, L. M., Wetter, A., Kirchner, J., Kinner, S., Aktas, B., Forsting, M., Ruhlmann, V., & Umutlu, L. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2016.12.019 · Cited by 30
Becker, M., Stefanelli, S., Rougemont, A., Poletti, P. A., & Merlini, L. (2017) · Neuroradiology · doi:10.1007/s00234-017-1798-y · Cited by 30
“PETMRI is technically feasible in children as young as 6 years of age without general anesthesia, showing comparable accuracy to PET CT [17].”
BackgroundResultInfluentialPerformance Study of a Radio-Frequency Field-Penetrable PET Insert for Simultaneous PET/MRI
Chang, C., Lee, B. J., Grant, A. M., Groll, A. N., & Levin, C. S. (2018) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2018.2852686 · Cited by 30
“make PET/MRI a preferred modality for pediatric patients [10] and those requiring repeat studies.”
BackgroundSpijkers, S., Littooij, A. S., Kwee, T. C., Tolboom, N., Beishuizen, A., Bruin, M. C. A., Elias, S. G., van de Brug, T., Enríquez, G., Sábado, C., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07182-0 · Cited by 30
Pujara, A. C., Raad, R. A., Ponzo, F., Wassong, C., Babb, J. S., Moy, L. P., & Melsaether, A. N. (2016) · The Breast Journal · doi:10.1111/tbj.12569 · Cited by 33
An overview of PET/MR, focused on clinical applications
Catalano, O. A., Masch, W. R., Catana, C., Mahmood, U., Sahani, D. V., Gee, M. S., Menezes, L., Soricelli, A., Salvatore, M., Gervais, D. A., et al. (2016) · Abdominal Radiology · doi:10.1007/s00261-016-0894-5 · Cited by 30
“accuracy for detecting malignant lesions in pediatric patients across a wide range of cancer types [56, 57].”
BackgroundKirchner, J., Deuschl, C., Schweiger, B., Herrmann, K., Forsting, M., Buchbender, C., Antoch, G., & Umutlu, L. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3726-0 · Cited by 28
Pediatric Oncologic Imaging: A Key Application of Combined PET/MRI
Gatidis, S., la Fougère, C., & Schaefer, J. F. (2016) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0041-109513 · Cited by 30
Self-citationSPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations
Voss, S. D. (2023) · Pediatric Radiology · doi:10.1007/s00247-023-05597-7 · Cited by 28
Nuclear Medicine in Pediatric and Adolescent Tumors
Kıratlı, P. Ö., Tuncel, M., & Bar‐Sever, Z. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.01.004 · Cited by 27
PET/MR in the Assessment of Pediatric Histiocytoses
Sher, A. C., Orth, R. C., McClain, K. L., Allen, C. E., Hayatghaibi, S. E., & Seghers, V. J. (2017) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001717 · Cited by 26
Advancement of MR and PET/MR in Prostate Cancer
Lindenberg, L., Ahlman, M. A., Türkbey, B., Mena, E., & Choyke, P. L. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.07.001 · Cited by 30
New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions
Schiano, C., Soricelli, A., de Nigris, F., & Napoli, C. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1561283 · Cited by 26
Branchini, M., Zorz, A., Zucchetta, P., Bettinelli, A., Monte, F. D., Cecchin, D., & Paiusco, M. (2019) · Physica Medica · doi:10.1016/j.ejmp.2019.03.005 · Cited by 25
Mhlanga, J. C., Lai, H., Alazraki, A. L., Cho, S. Y., Nadel, H. R., Pandit-Taskar, N. D., Qi, J., Rajderkar, D. A., Voss, S. D., Watal, P., et al. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29968 · Cited by 36
(CWS), O. B. O. T. C. W. S., Scheer, M., Dantonello, T. M., Brossart, P., Dilloo, D., Schweigerer, L., Feuchtgruber, S., Sparber‐Sauer, M., Vokuhl, C., Bielack, S., et al. (2018) · Pediatric Radiology · doi:10.1007/s00247-017-4066-8 · Cited by 25
Colleran, G., Kwatra, N. S., Oberg, L., Grant, F. D., Drubach, L. A., Callahan, M. J., MacDougall, R. D., Fahey, F. H., & Voss, S. D. (2017) · Cancer Imaging · doi:10.1186/s40644-017-0130-8 · Cited by 24
“Although this review is focused on PET/CT, it should be noted that PET/MR has been shown to result in substantial reductions in radiation dose to the patient, primarily due to the elimination of the CT component of the PET/CT [23, 24].”
MethodVerhagen, M. V., Menezes, L., Neriman, D., Watson, T. A., Punwani, S., Taylor, S. A., Shankar, A., Daw, S., & Humphries, P. D. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.260059 · Cited by 25
Frush, D. P., Callahan, M. J., Coley, B. D., Nadel, H. R., & Guillerman, R. P. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30298 · Cited by 40
Gückel, B., Gatidis, S., Enck, P., Schäfer, J. F., Bisdas, S., Pfannenberg, C., & Schwenzer, N. F. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000177 · Cited by 25
“Concerning noise exposure, only earplugs (no headphones) could be used in this study because of the resulting PET attenuation, which has not yet been accounted for.(13) With the use of headphones in the future, it will be possible to reduce noise exposure and improve patient compliance, for example, by playing music o…”
BackgroundMethodSelf-citationPark, H. Y., Suh, C. H., & Kim, S. (2022) · Korean Journal of Radiology · doi:10.3348/kjr.2022.0741 · Cited by 27
“” “Diagnostic yield” was used incorrectly as “diagnostic performance” in two studies [10,11], while “detection rate” was incorrectly used as “sensitivity” in 20 [44,46,51,52,54-62,70,74-76,78-80].”
BackgroundPET/MR Technology: Advancement and Challenges
Bogdanović, B., Solari, E. L., Asiares, A. V., McIntosh, L., van Marwick, S., Schachoff, S., & Nekolla, S. G. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2021.11.014 · Cited by 23
Sepehrizadeh, T., Jong, I., DeVeer, M., & Malhotra, A. K. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109987 · Cited by 21
PET/MRI in Pediatric Neuroimaging: Primer for Clinical Practice
Pedersen, C. K., Aboian, M., McConathy, J., Daldrup-Link, H. E., & Franceschi, A. M. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7464 · Cited by 21
“Hybrid PET/MR imaging is particularly promising in pediatric neuroimaging because it allows functional and soft-tissue characterization with a low radiation dose and comparable agreement with PET/CT reported in several recent studies.(5,6,9) Unlike PET applications in body imaging, the CT component of brain PET/CT typ…”
Background18F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed?
Kirchner, J., Deuschl, C., Grueneisen, J. S., Herrmann, K., Forsting, M., Heusch, P., Antoch, G., & Umutlu, L. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3635-2 · Cited by 20
“As described in previous publications [24, 25], lesions that were identified on PET/MRI and could not be identified on PET/CT were only included in our ratings if follow-up imaging was available.”
Mikhaylova, E., Tabacchini, V., Borghi, G., Mollet, P., D‘Hoe, E., Schaart, D. R., & Vandenberghe, S. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa8eb2 · Cited by 20
Do myocardial PET–MR and PET–CT FDG images provide comparable information?
Oldan, J. D., Shah, S. N., Brunken, R. C., DiFilippo, F. P., Obuchowski, N. A., & Bolen, M. A. (2015) · Journal of Nuclear Cardiology · doi:10.1007/s12350-015-0159-7 · Cited by 19
Transmission imaging for integrated PET-MR systems
Bowen, S., Fuin, N., Levine, M. A., & Catana, C. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/15/5547 · Cited by 19
“For oncological imaging, PET-MR may aid in the local staging, restaging, and therapy response monitoring of head and neck (Queiroz et al. 2014), breast (Pace et al. 2014), pelvis (Wetter et al. 2013), and pediatric (Schäfer et al. 2014) cancers.”
MethodInglese, M., Cavaliere, C., Monti, S., Forte, E., Incoronato, M., Nicolai, E., Salvatore, M., & Aiello, M. (2018) · NMR in Biomedicine · doi:10.1002/nbm.4026 · Cited by 20
Zucchetta, P., Branchini, M., Zorz, A., Bodanza, V., Cecchin, D., Paiusco, M., & Bui, F. (2019) · British Journal of Radiology · doi:10.1259/bjr.20180438 · Cited by 18
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients
Georgi, T., Stoevesandt, D., Kurch, L., Bartelt, J. M., Hasenclever, D., Dittmann, H., Ferda, J., Francis, P., Franzius, C., Furth, C., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264112 · Cited by 18
Hybrid imaging in Crohn's disease: from SPECT/CT to PET/MR and new image interpretation criteria
Catalano, O. A., Maccioni, F., Lauri, C., Auletta, S., Dierckx, R., & Signore, A. (2018) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.17.03053-9 · Cited by 19
“60, 61 The geometry of the PeT components of the PeT/ Mr scanners, with the resultant increased sensitivity in the center of the PET field of view (FOV), allows reducing activity to up to 30-50% of that required for comparable quality PeT from PeT/cT. 62 Moreover, the lengthier times required to…”
BackgroundLu, X., Calabretta, R., Wadsak, W., Haug, A. R., Mayerhöfer, M., Raderer, M., Zhang, X., Li, J., Hacker, M., & Li, X. (2022) · Life · doi:10.3390/life12071039 · Cited by 17
Magnetic resonance imaging based functional imaging in paediatric oncology
Manias, K., Gill, S. K., MacPherson, L. K. R., Foster, K., Oates, A., & Peet, A. C. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.037 · Cited by 21
Spijkers, S., Littooij, A. S., Kwee, T. C., Tolboom, N., Beishuizen, A., Bruin, M. C. A., Enríquez, G., Sábado, C., Miller, E., Granata, C., et al. (2021) · European Radiology · doi:10.1007/s00330-021-08026-1 · Cited by 16
“Moreover, in many hospitals around the world, a contrast-enhanced CT is still part of standard clinical procedures [4].”
BackgroundBarajas, R., Krohn, K., Link, J., Hawkins, R. A., Clarke, J. L., Pampaloni, M. H., & Cha, S. (2016) · Biomedicines · doi:10.3390/biomedicines4040024 · Cited by 17
“Finally, simultaneous PET/MR imaging with newer time of flight based digital detectors allows for marked dose reduction as high as 73% to the patient [82,83].”
BackgroundBaratto, L., Nyalakonda, R., Theruvath, A. J., Sarrami, A. H., Hawk, K. E., Rashidi, A., Shen, S., States, L. J., Aboian, M., Jeng, M., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06122-6 · Cited by 15
“The introduction of integrated PET/MRI scanners have reduced the radiation exposure of 2-[18F]FDG PET scans by more than 80% compared to PET/ CT (29).”
BackgroundRoy, P., Lee, J. K. T., Sheikh, A., & Lin, W. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.15.14450 · Cited by 15
“In addition, PET/MRI has also been shown to be equivalent to PET/CT in the detection of solid tumors in pediatric patients [4], identification of osseous metastases [5], and assessment of pulmonary masses [6].”
Morakote, W., Baratto, L., Ramasamy, S. K., Adams, L. C., Liang, T., Sarrami, A. H., & Daldrup-Link, H. E. (2023) · European Radiology · doi:10.1007/s00330-023-10015-5 · Cited by 15
Huang, C., Song, T., Mukherji, S. K., Zhang, L., Lu, J., Chen, X., & Xian, J. (2020) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001036 · Cited by 15
“25% lower radiation dose compared with PET/CT.19,20 The whole-body PET/CT radiation dose was about 25 mSv, of which 5.7 to 7 mSv came from tracer, 14.1 to 18.6mSvwas derived from CT scan.21 The PET/MR uses a different attenuation correction method comparedwith PET/CTwhich could result in confounding results.”
BackgroundInfluentialClinical utilization of whole-body PET/MRI in childhood sarcoma
Qi, J., Thakrar, P. D., Browning, M. B., Vo, N. J., & Kumbhar, S. S. (2020) · Pediatric Radiology · doi:10.1007/s00247-020-04834-7 · Cited by 14
“A small number of preliminary studies that included sarcomas among other pediatric malignancies have demonstrated PET/ MRI to be a reliable staging modality with a similar lesion detection rate compared to PET/CT with the added benefit of less radiation exposure [5, 6].”
BackgroundMR-PET of the body: Early experience and insights
Ramalho, M., AlObaidy, M., Catalano, O. A., Guimarães, A. R., Salvatore, M., & Semelka, R. C. (2014) · European Journal of Radiology Open · doi:10.1016/j.ejro.2014.09.001 · Cited by 15
18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis
Niu, J., Liang, J., Feng, Q., Wang, M., Wang, L., Ge, X., Wang, X., & Ding, Z. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s327134 · Cited by 13
Dose optimization: a review of CT imaging for PET attenuation correction
Brady, S. L., & Shulkin, B. L. (2017) · Clinical and Translational Imaging · doi:10.1007/s40336-017-0232-0 · Cited by 13
Overview and Recent Advances in 18F-FDG PET/CT for Evaluation of Pediatric Lymphoma
Guja, K. E., Nadel, H. R., & Iagaru, A. H. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.10.001 · Cited by 12
Waelti, S. L., Skawran, S., Sartoretti, T., Schwyzer, M., Gennari, A. G., Mader, C. E., Treyer, V., Kellenberger, C. J., Burger, I. A., Hany, T. F., et al. (2023) · European Radiology · doi:10.1007/s00330-023-10319-6 · Cited by 16
“With PET/MR, all of the radiation exposure derives from the injected [ 18 F] FDG [27–29].”
Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton
Stefanelli, S., Mundada, P., Rougemont, A., Lenoir, V., Scolozzi, P., Merlini, L., & Becker, M. (2018) · Insights into Imaging · doi:10.1007/s13244-018-0623-4 · Cited by 12
Imaging in pediatric renal transplantation
Damasio, M. B., Müller, L. O., Piaggio, G., Marks, S. D., & Riccabona, M. (2017) · Pediatric Transplantation · doi:10.1111/petr.12885 · Cited by 11
Gillman, J. A. M., States, L. J., & Servaes, S. E. (2020) · PET Clinics · doi:10.1016/j.cpet.2020.03.007 · Cited by 13
Metadata
- Authors
- Schäfer, J. F., Gatidis, S., Schmidt, H., Gückel, B., Bezrukov, I., Pfannenberg, C. A., Reimold, M., Ebinger, M., Fuchs, J., Claussen, C. D., & Schwenzer, N. F.
- Affiliations
- University of Tübingen (DE)
- Max Planck Institute for Intelligent Systems (DE)
- University Children's Hospital Tübingen (DE)
- ORCID
- Venue
- Radiology
- Published
- 2014-10
- Volume
- 273
- Issue
- 1
- Pages
- 220-231
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2161811075
- Cited by
- 215
- References
- 28
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 15 · 2022: 18 · 2021: 15 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 35 · 2016: 41 · 2015: 24 · 2014: 3
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Radiological Society of North America
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiation Dose and Imaging
- Keywords
- PET/MR, PET/CT comparison, pediatric oncology, 18F-FDG, standardized uptake value, radiation dose reduction, lesion detection, solid tumors, pediatric radiation exposure, soft tissue imaging, bone marrow imaging, lung imaging, image quality assessment, image fusion
- MeSH terms
- Adolescent, Child, Contrast Media, Female, Humans, Magnetic Resonance Imaging, Male, Neoplasms, Prospective Studies, Radiation Dosage, Tomography, X-Ray Computed, Positron-Emission Tomography, Whole Body Imaging, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.